1. Anicetti, V. R., Fehskens, E. F., Reed, B. R., Chen, A. B., Moore, P., Geier, M. D., and Jones, A. J. S. (1986),J. Immunol. Meth. 91, 213.
2. Baker, R. S., Schmidtke, J. W., Ross, J. W., and Smith, W. C. (1981),Lancet 2, 1139.
3. Ross, J. W., Baker, R. S., Hooker, C. S., Johnson, I. S., Schmidtke, J. R., and Smith, W. C. (1982), inHormone Drugs: Proceedings of the FDA-USP workshop on drug and reference standards for insulins, somatropins, and thryoid-axis hormones, Bethesda, Maryland, May 19-21, 1982, Gueriguian, J. L., Bransome, E. D., and Outschoorn, A. S., eds., United States Pharmacopeial Convention, Rockville, MD, pp. 127–138.
4. Ohmura, T., Ohmizu, A., Sumi A., Ohtani, W., Uemura, Y., Arimura, H., Nishida, M., Kohama, Y., Okabe, M., Mimura, T., and Heldebrant, C. M. (1987),Biochem. Biophys. Res. Commun. 149, 1172.
5. Chen, A. B., Fehskens, E. F., and Jones, A. J. S. (1990),Quantitaten of Chinese Hamster Ovary cell proteins in recombinant tissue-type plasminogen activator, unpublished observations.